Abstract:Radiation therapy prior to surgery has increasingly become the standard of care for locally advanced prostate cancer, however tumor radioresistance remains a major clinical problem. While restoration of microRNA-145 (miR-145) expression reduces chemoradioresistance in glioblastoma and suppress prostate cancer proliferation, migration and invasion, the role of miR-145 in response to radiation therapy for prostate cancer is still unknown. The aim of this study was to investigate the role of miR-145 in determining the tumor response to radiation treatment in prostate cancer. Human prostate cancer cells LNCAP and PC3 were transfected with miR-145 mimic. Clonogenic assay was used to determine whether overexpression of miR-145 could alter radiation response in vitro. Immunofluorescence of γ-H2AX and flow cytometric analysis of phosphorylated histone H3 were performed to investigate the potential mechanisms contributing to the enhanced radiation-induced cell killing induced by miR-145. In addition, a qPCR-based array was used to detect the possible miR-145-mediated regulated genes involved. Tumor growth delay assays and survival curves were then analyzed in an animal model to investigate whether miR-145 induced radiosensitivity in vivo. Furthermore, miR-145 expression was assessed in 30 prostate tumor tissue biopsies taken prior to neoadjuvant radiotherapy using miRNA arrays. Our current study suggested that ectopic expression of miR-145 significantly sensitized prostate cancer cells to radiation and we used γ-H2AX phosphorylation as a surrogate marker of radiotherapy response versus miR-145 expression levels. We observed significantly more foci per cell in the group treated with miR-145 and radiation. In addition, mitotic catastrophe was significantly increased in cells receiving miR-145 and radiation. The above results suggest that miR-145 appears to reduced the efficiency of the repair of radiation-induced DNA double-strand breaks in cells. A detailed examination of the involvement of the DNA repair pathway showed that miR-145 reduced the expression of 10 genes involved in DNA repair according to a qPCR-based array data. Irradiation of subcutaneous PC3 tumors in mice treated with R11-miR-145 (a cellular permeable peptide, previously reported) resulted in an increase in radiation-induced tumor growth delay and lived the longest after combination treatment. Moreover, miR-145 expression was significantly increased in patients demonstrating good response (PSA < 2.0 ng/ml/year) to neoadjuvant radiotherapy, while expression of the miR-145-regulated DNA repair genes was significantly decreased. In conclusion, these data suggest a possible mechanism for miR-145 radiosensitivity, potentially through down regulating of DNA repair. This novel study shows a role for miR-145 in modulating radiosensitivity in vivo and highlights the need for further study investigating the potential role of miR-145 as both a predictive marker of response and a novel therapeutic agent with which to enhance the efficacy of radiation therapy.

Abstract 4414: Radiation-induced Mir-5094 Expression Inhibits Cell Proliferation by Targeting STAT5b

The Role of MiR-5094 As a Proliferation Suppressor During Cellular Radiation Response Via Downregulating STAT5b

Radiation-induced Mir-208A Increases the Proliferation and Radioresistance by Targeting P21 in Human Lung Cancer Cells.

MiR-525-5p Modulates Cell Proliferation, Cell Cycle, and Apoptosis in Burkitt’s Lymphoma by Targeting MyD88 and Regulating the NF-κB Signaling Pathway

Analysis Of Mirna-Mrna Crosstalk In Radiation-Induced Mouse Thymic Lymphomas To Identify Mir-486 As A Critical Regulator By Targeting Igf2bp3 Mrna

Extracellular Mir-1246 Promotes Lung Cancer Cell Proliferation and Enhances Radioresistance by Directly Targeting DR5

Abstract P6-12-04: Targeting STAT3 with Novel Small Molecule Inhibitors to Sensitize Breast Cancer Cells to Radiation Therapy

Mir-4796 Enhances the Sensitivity of Breast Cancer Cells to Ionising Radiation by Impairing the DNA Repair Pathway.

Down Regulation of Mir-143 Promotes Radiation - Induced Thymic Lymphoma by Targeting B7H1

Abstract 705: miR-21-5p induces radioresistance through reinforced DNA damage response in oral squamous cell carcinoma

MiR-467a is Upregulated in Radiation-Induced Mouse Thymic Lymphomas and Regulates Apoptosis by Targeting Fas and Bax.

MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR

MiR-21 Plays an Important Role in Radiation Induced Carcinogenesis in BALB/c Mice by Directly Targeting the Tumor Suppressor Gene Big-h3

Inhibition of MicroRNA-21-5p Promotes the Radiation Sensitivity of Non-Small Cell Lung Cancer Through HMSH2

Mir-300 Regulates Cellular Radiosensitivity Through Targeting P53 and Apaf1 in Human Lung Cancer Cells

Mir-34A Suppresses Mutagenesis by Inducing Apoptosis in Human Lymphoblastoid TK6 Cells

MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer

MiR-495 Functions As an Adjuvant to Radiation Therapy by Reducing the Radiation-Induced Bystander Effect

Mir-144-5p Enhances The Radiosensitivity Of Non-Small-Cell Lung Cancer Cells Via Targeting Atf2

Inhibition of Mir-630 Enhances the Cell Resistance to Radiation by Directly Targeting CDC14A in Human Glioma.

Mir-205 Acts As a Tumour Radiosensitizer by Targeting ZEB1 and Ubc13